Immunic Therapeutics

Oral therapies for the treatment of chronic diseases

Immunic Therapeutics Logo
About Immunic Therapeutics

Development of small-molecule therapies

The Munich-based biopharmaceutical company develops selective, orally available therapies for the treatment of chronic inflammatory and autoimmune diseases, including multiple sclerosis, ulcerative colitis and Crohn’s disease. The company currently has three small molecule candidates in the development pipeline, which are being tested in various phase 1, 2 and 3 trials worldwide.

bmp Ventures Team

Oliver Borrmann

Founded

2016

Invested

2016

Stage

Expansion

Industry

Life Sciences & eHealth

Status

Aktiv